Multi-omics profiling reveals key factors involved in Ewing sarcoma metastasis

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Ewing sarcoma (EWS) is a rare bone cancer with poor prognosis, especially when metastatic.
• The molecular mechanisms driving EWS metastasis are not well understood, hindering treatment development.

Purpose of the Study:

• To investigate the molecular underpinnings of EWS metastasis using a multi-omics approach.
• To identify novel therapeutic targets for improving outcomes in metastatic EWS patients.

Main Methods:

• Utilized a spontaneous metastasis mouse model of EWS.
• Performed integrated transcriptomics, proteomics, and methylomics analyses on tumors and metastases.
• Validated candidate genes (CREB1, LOXHD1, FGD4) using phenotypic assays.

Main Results:

• Identified enriched signaling cascades and candidate genes in EWS metastases.
• CREB1 and LOXHD1 showed association with enhanced cell migration and clonogenic potential.
• FGD4 was identified as a CREB1 target, integrating multi-omics data and correlating with worse clinical outcomes.

Conclusions:

• Multi-omics profiling reveals key molecular drivers of EWS metastasis.
• CREB1 and its downstream target FGD4 represent potential therapeutic targets for EWS.
• Further research into these targets may improve survival rates for EWS patients.